Market Overview

Janney Capital Downgrades Cancer Genetics to Neutral

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real time — before the crowd.

Click here to get FREE 14-day trial of Benzinga Pro today.

Latest Ratings for CGIX

DateFirmActionFromTo
Apr 2018Maxim GroupDowngradesBuyHold
Dec 2017Maxim GroupInitiates Coverage OnBuy
Jun 2017Dawson JamesInitiates Coverage OnBuy

View More Analyst Ratings for CGIX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (CGIX)